UniCycive Therapeutics Inc (UNCY)

[Whalatane]

An AI analysis of those 126 pages

The April 30, 2026, proxy statement for Unicycive Therapeutics (UNCY) does not include a new "poison pill" or shareholder rights plan to limit a buyout. The filing centers on standard annual meeting matters, including director elections, executive compensation, and the upcoming June 2026 FDA PDUFA date for Oxylanthanum Carbonate.

There are " soft " poison pills already existing ...I'll try and copy and paste them

As of early 2026, Unicycive Therapeutics, Inc. (UNCY) does not appear to have a formal "Shareholder Rights Plan" (a traditional "hard" poison pill) active. Instead, the company utilizes several "soft" poison pills—standard corporate governance provisions designed to make a hostile takeover more difficult, expensive, or time-consuming.
These defensive measures, detailed in their SEC filings, include:
1. Blank Check Preferred Stock
The Board of Directors has the authority to issue up to 10 million shares of preferred stock without further shareholder approval.
Unicycive
Unicycive
The "Soft Pill": The board can assign these shares special voting, conversion, or dividend rights. In a hostile takeover attempt, they could issue these shares to a friendly party (a "White Knight") to dilute the hostile bidder's voting power.
2. Staggered (Classified) Board of Directors
Unicycive utilizes a classified board structure where directors are divided into three classes, with only one class up for election each year.
The "Soft Pill": This prevents a hostile bidder from replacing a majority of the board in a single election. It typically takes at least two annual meetings to gain control of the board, providing the current management with significant leverage to negotiate or seek alternative offers.
3. Restrictions on Shareholder Action
The company’s bylaws include several procedural hurdles for shareholders:
No Action by Written Consent: Shareholders generally cannot take action without a formal meeting, preventing a sudden "coups" via paper solicitation.
Special Meeting Limitations: Only the Board, the Chair, or the CEO can typically call a special meeting of shareholders.
Advance Notice Requirements: Shareholders must provide significant advance notice (often 90-120 days) to nominate directors or propose business at a meeting.
4. Strategic Assets and Concentration
Pipeline Single-Point Sensitivity: Much of UNCY's value is currently tied to the upcoming June 27, 2026 PDUFA date for its lead drug, oxylanthanum carbonate (OLC).
Insider Ownership: High levels of management or "friendly" institutional ownership can act as a natural deterrent, as a bidder would need their cooperation to achieve a majority.
GlobeNewswire
GlobeNewswire
+3
While these aren't "pills" in the sense of a triggerable right to buy cheap stock, they collectively function as a "soft" defense by slowing down any unsolicited acquisition attempt.

Kiwi